Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Nature Careers
- The University of Arizona
- Fred Hutchinson Cancer Center
- THE UNIVERSITY OF HONG KONG
- Baylor College of Medicine
- Stanford University
- University of North Carolina at Chapel Hill
- Aarhus University
- Forschungszentrum Jülich
- Technical University of Denmark
- University of Oxford
- Argonne
- Cornell University
- ICN2
- INSERM
- MOHAMMED VI POLYTECHNIC UNIVERSITY
- National Hellenic Research Foundation
- Texas A&M AgriLife
- UNIVERSITY OF SYDNEY
- University of Southern California
- University of Tübingen
- University of Virginia
- Virginia Tech
- Washington State University
- Angelo State University
- BENAJIBA team - INSERM U1342 - Saint-Louis Research Institute
- Central State University
- Delft University of Technology (TU Delft); yesterday published
- ETH Zürich
- Eindhoven University of Technology (TU/e)
- Eindhoven University of Technology (TU/e); yesterday published
- Emory University
- Gustave Roussy Cancer Campus
- Inria, the French national research institute for the digital sciences
- Institut Pasteur
- KINGS COLLEGE LONDON
- Karolinska Institutet (KI)
- Laboratoire d'Astrophysique de Marseille
- Leibniz
- Medical College of Wisconsin
- Northeastern University
- RCSI - Royal College of Surgeons in Ireland
- Rice University
- The Ohio State University
- Universidade de Coimbra
- University of Amsterdam (UvA); yesterday published
- University of Colorado
- University of Copenhagen
- University of Dundee;
- University of Florida
- University of Gdańsk, Intercollegiate Faculty of Biotechnology
- University of Lille
- University of Lund
- University of Luxembourg
- University of Massachusetts Boston
- University of Miami
- University of Minnesota
- University of South Carolina
- University of Southern California (USC)
- University of Southern Denmark
- University of Sydney
- University of Utah
- University of Washington
- Université de Bordeaux / University of Bordeaux
- Wayne State University
- Yale University
- Łukasiewicz Research Network - Krakow Institute of Technology
- 57 more »
- « less
-
Field
-
to the TARGET-SEC project's overarching goal of identifying novel therapeutic strategies targeting pro-tumorigenic stroma-epithelial interactions in CRC. The person will focus on applying innovative
-
experience in B and T cell immunology, or virology/ microbiology and a proven research track record. Strong communication skills and a good command of spoken and written English are essential. Applicants
-
Institute to address therapeutic targets which can be brought to the patient bedside. One Postdoctoral Fellow position is available in the Zhu lab. Our team is looking to add a motivated, ambitious, and
-
al., Nature Communications 2014; Martel et al., Journal of Neuroscience 2016). We also described epigenetic modifications and new gene targets of CREB-dependent transcription following learning
-
strategies, with specific targets established to track progress. The Fellow is expected to demonstrate the potential to contribute meaningfully to disability employment scholarship, collaborative team research
-
heuristic optimisation to explore and improve materials candidates-especially 2D/vdW structures-for target electronic/spintronic properties. The postdoctoral researcher will lead the optimisation component
-
disease progression are known and only one is FDA approved. ADPKD has many molecular and cellular commonalities with cancer, in which targeting metabolism and immune cell function have shown tremendous
-
to Applicants : Please attach a CV and a brief statement of research experience and interests in the Supporting Documents section of the application in a PDF format. Please note that the applicant tracking system
-
drug delivery carriers by modifying their surfaces, enabling active targeting of diseased tissues. Additionally, we explore the modification of cargo loading with target molecules. Our research also
-
Project description: The SHIELD consortium targets two closely related steps in the viral replication cycle that are, as yet, difficult to study and to exploit for therapeutic interventions: 1) Virion